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Abstract
Background: The core objective of any point-of-care (POC) testing program is to ensure that testing will result in
an actionable management decision (e.g. referral, confirmatory test, treatment), within the same clinical encounter
(e.g. POC continuum). This can but does not have to involve rapid tests. Most studies on POC testing focus on
one specific test and disease in a particular healthcare setting. This paper describes the actors, technologies and
practices involved in diagnosing major diseases in five Indian settings – the home, community, clinics, peripheral
laboratories and hospitals. The aim was to understand how tests are used and fit into the health system and with
what implications for the POC continuum.
Methods: The paper reports on a qualitative study including 78 semi-structured interviews and 13 focus group
discussions with doctors, nurses, patients, lab technicians, program officers and informal providers, conducted
between January and June 2013 in rural and urban Karnataka, South India. Actors, diseases, tests and diagnostic
processes were mapped for each of the five settings and analyzed with regard to whether and how
POC continuums are being ensured.
Results: Successful POC testing hardly occurs in any of the five settings. In hospitals and public clinics, most of
the rapid tests are used in laboratories where either the single patient encounter advantage is not realized or the
rapidity is compromised. Lab-based testing in a context of manpower and equipment shortages leads to delays.
In smaller peripheral laboratories and private clinics with shorter turn-around-times, rapid tests are unavailable or
too costly. Here providers find alternative measures to ensure the POC continuum. In the home setting, patients
who can afford a test are not/do not feel empowered to use those devices.
Conclusion: These results show that there is much diagnostic delay that deters the POC continuum. Existing rapid
tests are currently not translated into treatment decisions rapidly or are not available where they could ensure
shorter turn-around times, thus undermining their full potential. To ensure the success of POC testing programs,
test developers, decision-makers and funders need to account for such ground realities and overcome barriers to
POC testing programs.
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Background
Point-of-care (POC) tests have been hailed as an effi-
cient and innovative way to manage infectious diseases,
particularly in resource-poor settings, mainly to shorten
diagnostic delay and treatment initiation. Despite the
many definitions of POC testing [1–5], they all include
the critical elements of rapid turn-around-times (TATs)
to allow for quick diagnosis, and referral or treatment
decisions completed within the same patient encounter
(i.e. POC continuum) or at the very minimum, with re-
sults delivered on the same day. In a recent article, we
proposed a framework that envisions POC testing as
programs, rather than just tests, across five settings
(home, community, peripheral laboratory, clinic, and
hospital) [1]. POC testing understood in this way can in-
clude a spectrum of technologies (simplest to more so-
phisticated), users (lay persons to highly trained), and
settings. What matters is how tests are implemented in
the health system. This framework recognizes the inter-
dependence of different parts of the health system [6]
and the need for dialogue and policy consonance be-
tween health systems development and disease control
strategies [7].
Most articles on POC testing focus on cost-effectiveness,
feasibility, and acceptability related to one specific disease
in one of these settings [2–5, 8]. Recent exceptions are
studies on combined testing strategies for sexually trans-
mitted infections including HIV and syphilis [9, 10]. How-
ever, diseases do not occur in isolation, diagnostic tests are
not always conducted separately and settings are often
interlinked. Patients present with multiple or unspe-
cific symptoms, at different levels of care (in clinics,
health posts, laboratories or hospitals), in need of sev-
eral diagnostic tests in parallel that require interaction
among different types of healthcare workers. There-
fore, testing needs to fit into a variety of existing
daily work flow and care processes, and calls have
been made for more operational research into health
system requirements and impact of technologies on
diagnostic cycles and delays [11–13].
In order to develop new POC tests that function in
such dynamic and complex health systems, we need to
understand how major diseases are diagnosed and tech-
nologies for testing are used at different points of care
and to what effect [14]. In order to address this research
gap, we have studied how POC testing occurs across five
different settings in India and for a variety of major,
largely infectious, diseases. We examined the types of
prevalent diseases, what is being diagnosed, by whom
and when, the TATs involved and how test and treat cy-
cles are being completed. The aim was to comprehen-
sively describe how tests are used, by whom and how
they fit into the Indian health system and with what
implications for the POC continuum.
Methods
Data were collected as part of a qualitative research pro-
ject on barriers to POC testing. Data collection took
place between January and June 2013 in Bangalore, an
urban setting, and Tumkur, a rural district in Karnataka
(India). The urban setting is a predominantly poor
neighborhood, including one area that is considered a
slum, with a population of around 44,500 individuals
spread over 2.7 square km. Available healthcare services in
the area include two government health centres providing
outpatient care and outreach services, and 32 private pro-
viders from various systems of medicine including Unani,
Ayurveda, allopathy and homeopathy. The rural setting is
located 70 km outside Bangalore with an estimated popula-
tion of 2.7millions spread over 10,600 square km of which
80 % live in villages. The area includes a public district hos-
pital, nine sub-district hospitals, 160 primary health centres
(PHCs) and a range of private providers from informal to
highly specialized ones.
Data collection
Seventy eight semi-structured interviews were conducted
with healthcare providers (doctors, nurses, specialists, trad-
itional healers and informal providers), patients, commu-
nity health workers (CHWs), test manufacturers, laboratory
technicians, managers and policy-makers. Participants were
purposively sampled to represent the five settings of
hospitals, peripheral laboratories, clinics, communities
and homes in both the public/private sector and
rural/urban settings (Table 1). Additionally, 13 focus group
discussions (FGDs) were conducted with tuberculosis (TB)
and diabetic patients, CHWs, laboratory technicians, TB
program staff and medical officers at primary care
clinics, and with hospital nurses, all of which were
selected on a convenience basis to represent the dif-
ferent settings. The total number of FGD participants
was 94, with a median group size of six.
The semi-structured interviews and FGDs were con-
ducted jointly by Patil (MP) (a public health scientist
and physician) and Engel (NE) (a social scientist). The
topics explored included diagnostic processes for the
major diseases per setting (mainly HIV, TB, malaria,
hepatitis, syphilis, diabetes, typhoid and dengue) and
challenges therein, understanding of diagnosis, and vi-
sions of an ideal test. The interviews specifically exam-
ined diagnostic steps for each major disease occurring in
the setting in great detail from ordering a test to acting
on a result, including available material and capacities,
TATs, and referral processes (Additional file 1). The
FGDs focused exclusively on challenges experienced
when diagnosing. Interview and FGD guides were
piloted and revised during the fieldwork to improve clar-
ity of questions and translated into a local language
(Kannada). Interviews and discussions were held in
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Table 1 Participant overview per setting
Setting Type of participant No. of interviewed participants (interview code) Total
interviews
No. of FGDs (FGD code)
Urban public Urban private Rural public Rural private




2 (TB patient #1,
DM patient #1)
1 (TB patient #3) 2 (TB & DM patient
#5, TP patient #1)
7 3 (FGD #4, 10 - DM patients,
FGD #5 - TB patients)
Community Community Health Worker (CHW); Auxiliary-Nurse Midwife
(ANM); Accredited Social Health Activist (ASHA); Link Worker
(LW); Community Health Assistant (CHA)
0 0 2 (CHW #1, 2) 0 2 5 (FGD #2 – ANM, FGD
#3 – ASHA, FGD #7 – LW,
FGD #8 – ANM, FGD
#13 - CHA)
Clinic Specialist doctor (SP); Hospital Manager (HM); Private
practitioner (PP); Medical Officer (MO) Ayush Practitoner (AP)
2 (SP #6,
HM #2)
6 (PP #2, 3, 4,
11, 13, AP #1)
2 (MO #1, 2) 9 (PP #1, 6, 7, 8, 9, 10, 12,
14, 15)
19 1 (FGD #6 - MO)
Peripheral lab
(stand-alone)
Lab technician (LT); Lab Material Distributer (LMD); 4 (LT #6, 7,
8, LMD #1)
10 (LT #3, 4, 10, 11, 12,
13, 14, 15, 17, 18,)
14 1 (FGD #9 -LT)
Peripheral lab
(attached to clinic)
Lab technician (LT); Lab Manager (LM); Lab Specialist (LSP) 1 (LT #5) 1 (LM #2) 3 (LT #2, 19, 20) 3 (LT #1, LSP #4, 5) 8
Hospital Specialist provider (SP) 1 (SP #14) 5 (SP #8, 10,
11, 12, 13)
4 (SP #1, 2, 3, 15) 3 (SP #7, 9, 16) 13 0
Hospital Manager (HM); Program Officer (PO); Private
practitioner (PP)
0 1 (PP #5) 5 (PO #1, 2, 3, 4;
HM #1)
0 6 2 (FGD #11, 12 - TB PO)
Staff Nurse (SN) 0 0 5 (SN #1, 2, 3, 4, 5) 0 5 1 (FGD #1 -SN)
Lab technician (LT); Lab Manager (LM) 0 3 (LT 9#,
LM #1, 3)
1 (LT #16) 0 4 0
Total 78 13
Legend Table 1:
Home: TB tuberculosis, DM diabetes mellitus, TP typhoid patients
Community: ANM auxiliary-nurse midwife, ASHA accredited social health activist, CHA community health assistant, CHW community health worker, LW link worker
Clinic: AP ayush practitioner, HM hospital manager, MO medical officer, PP private practitioner, SP specialist doctor
Peripheral lab: LM lab manager, LMD lab material distributer, LT lab technician, LSP lab specialist













either English or Kannada, depending on the preference of
the participants. Aside from seven interviewees who re-
fused, all interviews and discussions were digitally re-
corded, and the note taker wrote down main points raised,
non-verbal communication and setting characteristics.
Data entry and analysis
Audio files and notes were transcribed and, if applicable,
translated into English. MP then checked and edited
those files, which were then cross-checked by NE. Data
analysis was done using Nvivo 9 (QSR International).
The study team jointly devised a coding scheme and
coded the material in close communication with each
other, further grouping material into emerging topics
and themes in an iterative manner [15–17]. For this
paper and in line with the above framework, actors, dis-
eases, tests and diagnostic processes were mapped for
each of the five settings and analyzed with regard to
whether and how POC continuums are being ensured.
Below, we have ordered our material along these five set-
tings and have discussed the cross-cutting themes of diag-
nostic processes and implications for the POC continuum
in each of these settings. A detailed analysis of the themes
that emerged on challenges in diagnosing at the POC is
published elsewhere [18]. In this paper, professional roles
are used to mask study participants’ identity.
Like every qualitative interview and group discussion
based study, we rely on statements by interviewees
which might have been biased (e.g. social desirability).
We enhanced rigor by triangulating findings across dif-
ferent informants and methods of data collection (e.g.
observations, interviews, FGDs). Furthermore, the joint
data collection and analysis of the collected material
allowed combining different professional perspectives.
Ethics
The study was approved by the ethics review board of
the Institute of Public Health, Bangalore, India, and the
ethics review board of the McGill University Health
Centre (MUHC), Montreal, Canada. Approvals for inter-
views and discussions were sought from district and
local authorities as necessary. All participants were
provided with information sheets (in either English or
Kannada) explaining the objectives of the study and
all but the participants of FGD #10 diabetic patients
(who agreed to participation verbally) signed informed
consent forms prior to participation.
Results and discussion
The results (see Table 2 for an overview) describe how
diagnostic tests are used, by whom and with what impli-
cations for ensuring the POC continuum in five settings:
the home, the community, public and private sector
clinics, peripheral laboratories and hospitals. Each setting
employs different technologies and involves different
actors that influence diagnostic practices, and therefore
results are presented and discussed for their implications
for each setting separately.
Home setting
While some tests might be widely available for the pub-
lic to purchase, hardly any testing occurs in the home.
In our study, the glucometer is the most commonly
used diagnostic instrument at home, yet most of the dia-
betic patients we interviewed did not use it. While it is
easily available, only the more affluent can afford the
device (Rs1500 or USD24 and upwards) and its testing
strips (Rs1200 or USD20 for 50 strips). Even though the
results are instantaneous, some laboratory technicians
and doctors said that at home, patients do not check
their sugar levels daily or at different times of the day,
leading to inaccurate or inconclusive results (LT13, 14;
PP1, 3, 5, see Table 1 for explanation of interview codes).
A private laboratory technician in the rural area de-
scribed diagnostic practices of his diabetic patients:
Some of the diabetic patients come by themselves for
follow-up and blood glucose level. They come once in
15 or 20 days regularly to monitor. Some patients do
self-monitoring with glucometer but it is not accurate –
he does not know how to use it properly. (LT 3)
In our group discussions, diabetic patients could not
recall normal or abnormal blood sugar ranges (some of
them had never been explained the difference) (FGD#10
DM patients). Instead, most patients with blood sugar
conditions rely on monthly visits to doctors or laborator-
ies for routine monitoring or when symptoms such as fre-
quent urination, fatigue, hunger and itchy palms occur
(LT1-14). Similarly, urine pregnancy test kits are easily
available and more affordable than glucometers, but many
patients are unsure of how to use them, bringing the kits
to the doctor to administer the test (PP3).
Owning the POC device is not the same as knowing
how to use it and having the confidence to interpret the
results. Research on medical encounters in India has
shown that the doctor-patient relationship is often char-
acterized by medical paternalism, wherein patients’ in-
volvement is limited and dependent on the doctor’s
expertise [19, 20]. For testing in the home setting the
implications are that patients who are able to afford the
diagnostic devices are not or do not feel empowered to
use them.
Community setting
Community Health Workers (CHWs) in India act as a
link between the community and public health facilities
and are trained in identification of basic key symptoms,
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Table 2 Testing in home, community, clinic, peripheral lab and hospital settings
Setting Tests done By whom and where Completion of POC test and treat cycle Implications for POC
continuum
Home Glucometer, urine pregnancy Affluent, educated
only, done in home
or tests bought and
taken to doctor
Confirm urine pregnancy test with
doctor/lab; visit local doctor/lab
directly for monthly monitoring or if
have symptoms of high/low sugar;
Patients not able/empowered
to use diagnostic devices
Community Malaria smear (or rapid test if
endemic); urine pregnancy
ASHA, at doorstep Patient and sample referred to PHC;
results communicated to CHW (over
phone), CHWs visit patient to




















HIV rapid and HIV Coombs’ HIV mobile testing van
Clinic
(public sector)
Malaria smear; HbsAG card
(hepatitis), dengue NS1 card;
dengue IgG/IgM; VDRL card
(syphilis); glucometer; urine
pregnancy, HIV rapid or
Coombs; urine sugar
(Benedict’s); AFB sputum
for TB (in selected clinics)
Lab technician, done in
in-house lab, if no lab
facilities then referred to
public sector taluk or
district hospital
For morning samples results by
afternoon, doctor seen same day
unless test kits/reagents/doctor
unavailable, or tests out-sourced
Setting with shorter TATs, but
exclusive lab-based testing in
context of manpower and
equipment shortages leads to
delays
Malaria antigen Referred to public
sector taluk or district
hospital or private lab
Patient’s initiative required to get




Glucometer, urine pregnancy Private provider Immediate results Arrangements with private
labs nearby ensure POC




Rapid tests: Widal (typhoid),
malaria rapid test (rare), HBsAG,
dengue NS1, VDRL (syphilis),
glucometer, urine pregnancy
dipstick, HIV rapid, HB card, urine
sugar (Benedict’s). Others:
malaria smears, Mantoux, renal
and lipid function, x-rays, scans,
urine routine, blood grouping,
CBC, blood pressure
Lab technician; done in
in-house lab or nearby
peripheral lab.
Same day results Arrangements with private
providers nearby ensure POC
continuum using older, slower
but cheaper methods
Hormone tests Outsourced to larger
chains of private labs in
Bangalore/Mumbai




Blood sugar with glucometer;
urine sugar with dipstick
or Benedict’s solution;
haemoglobin by blotting paper
method, BTCT (Bleeding Time
Clotting Time), HIV Tridot, ECG





Treatment begins at bedside
once doctor has seen results
POC continuum ensured for
limited tests done in wards
Hospital
(in labs)
Rapid tests for HIV, malaria,
dengue, HBsAG, VDRL (syphilis),
Widal, urine pregnancy, chest
x-ray, renal and liver function
tests, complete blood count





Out-patients collect results from labs,
see doctor in afternoon/evening if
available; admitted patients: attenders
carry samples to labs, nurses collect
results if workload permits
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awareness creation and referral to health centres. Among
CHWs, auxiliary nurse midwifes (ANMs) also conduct de-
liveries. However, we found that only a very limited num-
ber of tests are being used in the field by CHWs. What is
more, their use is constrained by the lack of continuous
supply of equipment (test kits) due to shortage of funds.
Furthermore, once tested, the onus is on the patient to
follow-up with treatment at the clinic, while CHWs
struggle to convince and support patients, challenged
by transportation and manpower constraints.
CHWs mainly do symptom screening, collect malaria
blood smears for anyone with fever and sputum samples
for tuberculosis microscopy testing at homes or at health
camps. In urban areas, ANMs conduct pregnancy tests
and haemoglobin with Sahli’s haemoglobinometer as part
of ante-natal care check-ups. In rural areas ANMs also do
urine albumin and sugar, and malaria rapid diagnostic
tests in endemic areas (our study site was a non-endemic
area). In addition, HIV mobile testing vans, manned with
a laboratory technician and counsellors, conduct HIV
rapid tests and Coomb’s test in communities (PO4).
CHWs record patient details in the field and refer
those with positive or abnormal readings to the PHC for
further testing and treatment. It is the patient’s responsi-
bility to seek further care. Once at the PHC, patients are
often faced with non-availability of doctors, long waiting
times, repeat tests to confirm field tests, and informal
payments for investigations.
The TATs for samples that are being tested at public
clinics depend on the clinic setting (see below). Where
transportation is lacking, samples may dry up before
they reach the clinic and have to be re-taken. Several
CHWs reported stock-outs and non-availability of test
kits (FGD#3ASHA) and fear for their personal safety
when dealing with social problems like alcoholism and
domestic violence.
In the last 4 years, we have been given the [urine
pregnancy test] kits twice. After that they have not
given it to us and we have been calling the patients
here [to the PHC]. (FGD #3 ASHAs, Respondent 0)
The results of sputum samples and blood smears for
malaria are communicated to the CHW over the phone,
yet may not always reach the patient given the large
population CHWs have to cover and the limited man-
power and transportation resources they have.
CHWs told us that tests conducted at the doorstep
along with regular home visits can be a convincing tool
to seek care at PHCs (as results are immediate, visible
and free).
It is hard to bring patients to the PHC. The solution is
that we should be able to do it in the village itself near
their home or at the doorstep, whether it is treatment
or testing. For small things at least that should be
done and major problems that we can bring them to
PHC. (FGD #3 ASHAs, Respondent 1)
Yet, the CHWs in our study also warned that major
challenges would remain despite testing at the doorstep,
such as counselling patients on the spot to follow-up
with tests and treatment, especially for stigmatized dis-
eases like HIV and TB (CHW1&2), the cost for patients
in accessing care (transport, food and losing a day’s
wages) and lack of facilities or manpower at the PHCs
(CHW1&2, FGD#7LW, FGD#2ANM).
Community health workers (CHWs) are often seen as
important users of POC tests [21]. Our results confirm
that a doorstep delivery approach by CHWs can lessen
the onus on patients in accessing care, as has been
shown in general health service delivery in Bangladesh,
[22]. Yet, our results also show that health system chal-
lenges, such as lack of equipment and infrastructure
support [23], undermine the potential of CHWs to link
between patients, communities and healthcare providers.
Even if available, easy to operate and rapid, the diagnos-
tic technology alone cannot overcome these problems.
Public clinic setting
We found that a lack of funds restricts the availability of
rapid test kits in public clinics. Where rapid tests are
available, the test and treat cycle is not completed in one
patient encounter: rapid tests are conducted in small
laboratories challenged by workload and manpower,
resulting in too long TATs, and patients have to be
referred elsewhere for confirmatory testing for HIV
and TB, all of which can cause patient attrition.
Table 2 Testing in home, community, clinic, peripheral lab and hospital settings (Continued)
For TB: AFB sputum, ELISA
(tertiary private only)





Patients collect results from separate
labs for TB/HIV testing, return results to
doctor in afternoon if available
Legend Table 2:
AfB acid fast bacilli, ANM auxiliary nurse midwife, ASHA accredited social health activist, BTCT bleeding time clotting time, CBC complete blood count, CHW
community health worker, ECG electrocardiogram, ELISA enzyme-linked immunosorbent assay, ESR erythrocyte sedimentation rate, HBsAG hepatitis B surface
antigen, IgG/IgM immunoglobulin G/M, NS1 non-structural protein 1, PHC primary health centre, VDRL venereal disease research laboratory test
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The public clinic setting is represented by the most
basic unit of the Indian public health system, the PHC
in rural areas (urban health centres in urban areas)
staffed with one qualified physician and/or Ayush med-
ical officer, one to three staff nurses, two laboratory
technicians, four CHWs and one pharmacist. They pro-
vide preventative and curative treatment and implement
national disease control programs. All PHCs usually
have attached laboratories for conducting basic tests.
Every third or so PHC is equipped with TB microscopy,
but they do not have scanning or X-ray facilities. In
reality, PHCs are often understaffed with insufficient
laboratory facilities and funds for testing kits and la-
boratory consumables. This means that patients or
their samples are often sent to the next level of care
((sub-)district hospital).
Most tests at the clinic setting are conducted in the
PHC laboratory by a trained technician, including malaria
smears, HbsAg card test (hepatitis), HIV rapid and
Coomb’s tests, dengue NS1 card test and dengue through
IgG and IgM lab tests, urine dipstick, urine sugar testing
with Benedict’s solution, urine albumin, and total and dif-
ferential count of white blood cells. In some PHCs, the
HIV test is done by a technician sent by the HIV/AIDS
program on ante-natal care day (LT2, LT5). After 5 pm,
when laboratories close, staff nurses perform some tests,
such as glucometer, malaria smears and HIV rapid tests for
women in labour without ante-natal care or HIV reports
(SN1). According to doctors, the urine pregnancy test is
the only rapid test done during consultation, but confirma-
tory tests are sent to the laboratory (MO1&2).
High workloads lead to delays and backlogs. Doctors
see about 30 follow-up ante-natal care cases and 50 to
90 new patients per day (MO1,2). They send about half
of all patients seen for laboratory tests (LT20&19). La-
boratory technicians investigate 800 to 900 smears for
malaria a month including those sent by CHWs (LT,5,
19, 20), and about 200 routine random blood sugar tests
(with a glucometer) per month. One laboratory techni-
cian (LT2) said she does 35 ante-natal care test packages
a day (each including HBsAG via card, blood sugar with
glucometer, VDRL card test (syphilis) and blood group-
ing, with a total TAT of one hour).
Depending on patient load and doctor availability,
TATs can get delayed if doctors cannot be seen on the
same day.
For HIV, if the PHC has not procured the Tridot
card test for HIV, they use the Coombs Aid test
which takes more than an hour for a result. So
patients coming in the morning are told to return
by 2 to 3 pm and those who give samples in the
afternoon are told to come the next day which
could cause patient loss (LT19).
In the interim, some form of empirical treatment
could have begun, but no conclusive diagnoses would
have been made.
Patients who have tested positive for HIV at the clinic
have to go to a hospital for confirmatory testing (using
ELISA or rapid card tests) often without knowing their
result due to absence of trained counsellors at clinics
(LT18, 19).
If HIV is positive (…) we will not tell the patient…there
is no counseling here and also we do not have the two
confirmatory tests here, so we send them to the ICTC
center or to the general hospital (LT19).
The referral system is weak and informal, at which
point patient loss to follow-up occurs. A systematic re-
view of studies on patient loss between testing, con-
firmatory testing and treatment for HIV/AIDS in Sub-
Saharan Africa found that loss to follow-up happened
for more than two thirds of patients tested positive.
Lacking information system between facilities was found
to be among the factors causing patient loss, followed by
patients being asymptomatic, cost involved to access
testing and fear of social stigma [24].
Imbalanced resource allocation, limited physical access
to quality health services and inadequate human re-
sources [23] as well as inability to translate funds into
public health services [25] are well documented chal-
lenges of India’s primary health clinics. Our results show
that delays in TATs caused by equipment, workload and
manpower challenges in public laboratories are even
more disastrous in settings with weak counselling and
referral systems.
Private clinic setting
Coordination between private doctors and private la-
boratories encourage the use of the latter to perform
tests, and the alignment of consulting times. Private
practitioners tend to order chemical analysis tests over
rapid ones because of high costs and lacking faith in the
accuracy of the latter.
Private clinics in this study range from small out-
patient clinics with basic facilities, to clinics that manage
seven in-patients with small in-house laboratories, to lar-
ger nursing homes with wards, in-house laboratories and
operating theatres. Accordingly, the qualifications of
these providers range from basic in Ayurvedic or allo-
pathic medicine in small clinics to specialisation degrees
in larger centres. The unqualified providers often repre-
sent the first point of contact for patients in remote areas.
Most private clinics are open for out-patients in the
morning and again in the evening. Providers see an aver-
age of 60 patients a day (around 100 in larger nursing
homes) and spend between 5 to 15 minutes with each
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one. Average consultation charges range from Rs100 to
Rs150 (equivalent to USD1.6-2.5), with Rs30 (USD0.5)
for unqualified rural providers, up to Rs300 (USD4.5) in
larger nursing homes, although some fees are waived for
the poorest. Patients from far off villages also seek care in
private clinics when facilities closer to home fail them.
Private doctors rarely do any testing in their own
clinics and order the majority of tests in nearby laborator-
ies. According to private laboratory technicians (LT1-6),
the majority of doctors in private clinics get ‘kick-backs’
from laboratories for ordering tests, a commission ranging
from 20 to 40 % of the price paid by patients (PP1,6,11).
Most doctors preferred not to admit to having received a
commission and instead claimed not to keep track of how
many tests they order. When they admitted it, they
claimed to put the money back into the clinic’s infrastruc-
ture (e.g. to buy an ambulance), fund a local charity, or
allocate it for the poorest patients (PP 2–3,6,7,10). As a
doctor in a small rural clinic explained:
We will not worry about how much is coming [as
commission]. Whatever they [laboratories] give, we
will keep it for the poorest patients or donate to a
mosque or madrasa.(PP6)
We found that private clinics and laboratories often
coordinate their opening hours, allowing patients to be
seen by the doctor in the morning, get tested at the la-
boratory nearby during the day and return to the clinic
in the afternoon or evening with the results. This
ensures a POC continuum within the same day.
Pregnancy tests and glucometer (and ECG machines
for larger clinics) are the only tests commonly used in
private clinics on the spot with a TAT of minutes. These
tests are easily available at pharmacies (chemists) and
some patients bring them to the doctor (see home set-
ting). This shows not only the commonality of these
tests (and their associated conditions), but again that
some patients feel the need for a doctor’s expertise to
conduct tests or read their results.
Tests usually ordered by private doctors in local labora-
tories are: Widal (rapid slide test for typhoid), haemoglo-
bin by Sahli’s method (or semi-/automated in bigger
laboratories), CBC (complete blood count), platelet count,
HbsAG (card test) for fever with a TAT of 30 minutes to
1 hour for results while card tests produce instant results;
Mantoux, chest X-ray and microscopy for TB (done in
public sector laboratories) with a TAT of 3 days for final
confirmation; renal and liver function tests with TATs of
2 days, blood sugar, albumin, bilirubin, bile salts done
using chemical analysis in the laboratory with TATs of
30 minutes (in-house or referred outside depending on fa-
cilities present); tests like thyroid hormone levels take 3–4
days and are sent to large private laboratories.
Many private providers lack faith in the accuracy of
rapid test kits that are often too expensive for patients
(for instance Rs800 for a dengue NSI card test). Instead,
they order laboratory tests that use chemical analysis
(i.e. to confirm pregnancy and blood sugar) and micros-
copy (PP1, 13). Unqualified practitioners in rural areas
we spoke to generally administer steroid injections for
temporary relief, but also intravenous fluids and insulin
injections for previously diagnosed diabetic patients (pa-
tients bring their own syringes). On the spot, they only
check blood pressure and temperature and send cases of
fever and diarrhoea to laboratories nearby (PP8&9).
With poorer patients, many private practitioners in
small clinics prefer clinical diagnosis over investigations
that patients cannot afford.
The reason I do not prefer to go for investigations is
the high cost. Most of the patients cannot afford it and
we don’t like to force them. (PP5)
Most providers claimed that they refer TB suspects
(prolonged cough, positive X-rays) to the government
TB facility for confirmation and free treatment. Our in-
terviews with TB patients showed that this only hap-
pened after repeated misdiagnosis and mistreatment
with frequent provider change (e.g.. TB Patient 5). HIV
is diagnosed using rapid tests in laboratories but for con-
firmatory ELISA tests, patients are sent to the govern-
ment’s national HIV/AIDS facility. Those referrals are
often done without revealing positive results to patients
to avoid losing them (LT6,18).
If they are illiterate we don’t tell them we are sending
for HIV or TB – they will get scared and won’t come
back with the result or get the test done. (PP12)
Patients are referred to larger hospitals also for more
complex cases such as pregnant women with pedal
edema (PP3). Since there is no formal referral system be-
tween private and public providers and often limited
counselling, loss to follow-up can occur with similar
consequences for the POC continuum as discussed for
public clinics.
In light of a poorly funded public sector, India’s large
and unregulated private healthcare sector is the pre-
ferred choice by poor and better-off Indians alike, al-
though many private providers perform unnecessary
diagnostic tests and surgical procedures with at times
questionable quality [26–29]. Our interviews with TB
patients, for instance, show that delays caused by re-
peated misdiagnosis are particularly long if private pro-
viders are visited first [30–32]. The limited use of tests
on the spot by private doctors and their doubts about
the accuracy of rapid tests and cost for patients confirm
Engel et al. BMC Health Services Research  (2015) 15:550 Page 8 of 13
earlier studies on clinicians’ attitudes towards POC testing
[5, 33]. While kick-backs between private doctors can en-
courage inadequate tests to be widely used [29] and foster
mismanagement of TB [31], we find that the POC con-
tinuum is often ensured because of these arrangements.
Peripheral laboratories (private)
The high cost of rapid kits and reagents prohibits their
use in poorer neighborhoods where most small labora-
tories are located. But due to smaller volumes, these la-
boratories are able to maintain a one hour TAT using
older methods. Larger laboratories do use rapid tests, es-
pecially for self-referrals, but patients still have to collect
results and return to a doctor. Coordination between
doctors and laboratories helps maintain the POC contin-
uums, as do arrangements between polyclinics and in-
house diagnostic centres.
Our study included a variety of private laboratories
from small one-roomed ‘shops’ performing a simple
array of tests, to medium-sized facilities, to large chains
of diagnostic centres with headquarters in the state’s
capital. The smaller laboratories have basic infrastructure,
some with only benches and no waiting areas or beds. All
seemed to have a refrigerator and a power back-up system,
though only for a few hours. Medium-sized laboratories
have waiting areas, but only small one-roomed testing fa-
cilities where equipment is stored. The larger more well
equipped laboratories have at least one chemical analyzer
(semi-automatic or automatic), a centrifuge, incubator,
microscope, and two to three technicians.
Smaller laboratories have a workload of around 10 to
30 patients a day, with medium-sized facilities working
with around 50 samples a day. Most laboratories are
open from 8 am until 10 pm. The morning rush of regu-
lar diabetic patients testing fasting blood sugars tends to
delay TATs from one hour to two. As the day progresses
and patients are being referred from the clinics, the la-
boratories perform a variety of tests including: HB card
method, random blood sugar (glucometer or manual),
urine dipstick or chemical analyser, platelets, CBC, malaria
using microscope (rarely rapid card test), blood grouping,
HBsAG, VDRL, typhoid slide (Widal), TB Mantoux and
HIV Tridot. The TATs for most tests is one hour. The
TAT of a rapid test extends to one hour if ordered with a
battery of other tests using older methods.
In all laboratories, patients can collect results in the
afternoon for samples given in the morning and samples
given in the afternoon are collected in the evening or
the next day. Patients collect reports directly from the
laboratories and then queue at their doctor for interpret-
ation of results. Some patients are too poor to pay for
results and fail to collect them. To counter their finan-
cial losses, laboratories tend to ask patients for partial
payment upfront.
The high costs of rapid card tests compared to older
methods (Table 3) is a key reason why smaller laborator-
ies in poor neighborhoods do not use rapid tests. An ex-
ception is the newer slide test for typhoid which takes
20 minutes and is cheap (Rs50, USD0.85) and thus pre-
ferred over the older tube test which takes 24 hours and
is more expensive (Rs250, USD 4.15). Some expensive
tests like cholesterol and lipid profiles are rarely done
except for those with private health insurance. The costs
of testing equipment (analyzers, microscopes), rapid test
kits and reagents force smaller laboratories to invest in
older, cheaper, and potentially less accurate methods. At
the same time, laboratories face stiff competition from
polyclinics that have started in-house diagnostic centres.
The diagnostic process between clinics and laborator-
ies is at times altered on patients’ or laboratory techni-
cians’ initiatives: patients with fever access laboratories
specifically requesting malaria, typhoid and dengue tests
to avoid queuing at the doctor’s clinic first (LT 6,16). A
laboratory technician illustrates: “The fever comes they
think it is typhoid or dengue so they ask us, we send them
saying consult a doctor and come. (LT18) While public
sector laboratory technicians have been instructed to test
anyone with fever, private laboratory technicians advise
the patient to see the doctor first. But given that most la-
boratories are under pressure to make a profit, they are
likely to do the patient’s bidding and also interpret test
results so that patients can choose if they want to con-
sult the doctor.
‘I will do three tests but I will not be responsible for
what the doctor says’. When they come without
consulting the doctor, we will have to tell them that.
‘For fever, there are many tests, we cannot do all of
them, we can do two or three of the tests- but if you
force us’. (LT18)
Yet, many laboratory technicians refuse self-referred pa-
tients for HIV testing without a doctor’s referral as com-
municating a positive result causes more problems for the
laboratory without proper training or counselling facilities
(e.g. to newly married couples in case one partner tested
positive or when patients are unwilling to accept a result
and might blame the laboratory for it) (LT18, 19).
Sometimes people come on their own for HIV and we
just reject the test and (…) send them away saying ‘We
cannot do it, it is done free at the government hospital.’
… They can go there and get it done, we tell them,
‘We do not want your money, we do not want you to get
in to problem and then create problems for us’ (LT18)
In private laboratories, counselling for HIV does not
take place and patients are rarely told they are being sent
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to the public HIV/AIDS program for confirmation of HIV
because of social stigma; when the rapid results are posi-
tive for HIV, most laboratories tell the patient that the test
wasn’t available or the machine was not working.
It is estimated that India has over 100’000 diagnostic
laboratories with only 1 % being accredited [34]. Despite
the lack of quality control and accreditation, India’s large
numbers of small peripheral laboratories are frequently
accessed by patients and thus important players in POC
testing. We show how self-referrals and the time-saving
tactics used by patients turn the diagnostic process on
its head: completing tests before visiting a doctor.
Furthermore, our results highlight that these laboratories
manage to ensure POC continuums by using older
methods than rapid tests and ensuring coordination with
the treating provider. The tendency for keeping patients
uninformed and maintaining medical paternalism in
doctor-patient relationships [19, 20] is extended to
patient-laboratory technician encounters, adding to con-
fusion and patient attrition
Hospital setting
Tertiary hospitals (public, private, medical colleges) tend
to use more rapid tests than most other settings, in the
Table 3 Cost of tests in rural and urban, private peripheral labs (LT #4-9, 12,17, PP#2)
Name of test Cost
Glucometer Rs40 (USD0.65)
Blood grouping Rs45 (USD75)
Urine test Rs50 (USD0.85)
Typhoid slide (Widal) Rs50 (USD0.85)
Haemoglobin Rs50 (USD0.85)
FBS, PPBS blood sugar (manual) Rs60 (Rs25) (USD1, USD0.40)
Platelet Rs80-Rs150 (USD1.35-USD2.50)
Albumin Rs100 (USD1.65)
Urine pregnancy test Rs100 (USD1.65)
Malaria smear Rs100 (USD1.65)
Smear for acid fast bacilli (TB) Rs100 (USD1.65)
Mantoux Rs100 (USD1.65)
VDRL (syphilis) Rs100 (USD1.65)
Sputum Rs120 (USD2)
HbsAG card (hepatitis) Rs120 (USD2)
Coombs test (HIV) Rs150 (USD2.50)
HIV rapid (Tridot) Rs200 (USD3.30)
Complete blood count (CBC) Rs250 (USD4.15)
Typhoid tube Rs250 (USD4.15)
Malaria card Rs300 (USD5)
Blood/Urine/pus Culture & sensitivity Rs250 to Rs350 (USD4.15-USD5.85)
HIV 1 & 2 (serology) RS350 (USD5.85)
Thyroid hormone assays Rs350 (USD5.85)
Fever profile Rs400 (USD6.65)
Lipid profile Rs400 (USD6.65)
Renal profile Rs600 (USD10)
TB Rs650 (USD10.85) (X-ray: Rs200 (USD3.35); CBC: Rs250 (USD4.15);
Sputum: Rs100 (USD1.65); Mantoux: Rs100 (USD1.65))
Dengue NS1 card test Rs750 (USD12.50)
Ante-natal profile (haemoglobin, random blood sugar,
HBsAG, VDRL, HIV, urine routine, blood grouping)
Rs750 (USD12.50)
TB serology Rs900 (USD15)
Polymerase chain reaction (PCR) Rs1500 (USD25)
Fertility related hormone assays Rs15,000 (USD249.75)
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wards (for in-patients) and in the laboratory. Yet, the
majority of rapid tests are done in laboratories. This fails
to use them to their full potential and jeopardizes the
POC continuum with outpatient department (OPD) and
in-patients having to wait half a day for results (3–4
hours) unless it’s an emergency, in which case the TATs
are immediate. Particularly for HIV and TB tests, pa-
tients have to shunt between locations risking further
delays and loss to follow-up.
Poor people tend to seek care in public hospitals [35]
as treatment is free, although quality of services may be
poor and there are additional costs such as travel and
food. Only the middle and upper classes can afford treat-
ment at private hospitals, while private medical colleges
operate at the mid-price range, offering subsidized rates
for all people. The latter tends to offer better quality of
care than the public sector at a cheaper price than
private hospitals.
Most doctors in hospitals, especially specialists, say
they rely less on diagnostic tests and more on clinical
findings. There is no defined protocol for ordering tests,
other than less obvious conditions may require a battery
of tests while the more clinically evident conditions re-
quire less tests (SP 2,9,10,14). However, private hospitals
catering to a higher socio-economic clientele tend to
order a series of tests, while those catering to poorer
patients order the basic minimum tests to save the
patient money.
I hate the word ‘Corporate’ because corporate hospitals
charge a lot and I do not want to follow that…Here we
try to think what less investigations, less tests, less
medications are required…to arrive at a diagnosis to
treat the patient at an affordable cost.(SP 9)
In public and private hospitals, diagnostic tests include:
malaria smear and rapid test (only in an emergency due to
high costs), dengue NS1 and ELISA, urine routine, Widal,
renal and liver function tests, complete blood count, plate-
let count and Tridot and ELISA for HIV. All tests are
done in the laboratory except RBS by glucometer, ECG,
urine dipstick test and HIV Tridot for pregnant women
which are done in wards by staff nurses and post-graduate
medical students.
All TB patients are offered free HIV testing in public
hospitals. HIV and TB tests are processed in separate la-
boratories: patients need to go to those rooms in the
OPD block and return to collect reports. Patients being
tested for HIV, TB as well as co-morbidities have to visit
up to three different locations for tests and to collect re-
sults, rather than a single visit at a centralised labora-
tory. While private secondary and tertiary hospitals may
have centralised laboratories, some private hospitals send
patients to public hospitals for confirmatory testing for
HIV (ELISA) and TB (AFB sputum) and/or treatment
initiation (Lab Manager 1, PP5, TB patient 4).
On average, in all hospital settings (rural and urban,
and public and private), the TAT for diagnostic tests
done in the in-house laboratory is about three to four
hours between the morning (9 am to 2 pm) and after-
noon OPD (2 pm to 4:30 pm). Patients or their attenders
have to collect laboratory results and then see the doctor
in the afternoon OPD for further decisions to be taken.
The TAT for specialised tests (culture and hormonal
tests) takes 24 hours in private tertiary hospitals (due to
electronically available results (Lab manager 1)) and
from 48 to 72 hours in public tertiary and private
secondary hospitals.
Delays in TAT can happen when repair of equipment
and purchase of reagents are delayed; also rapid tests are
too expensive for public hospitals, and a high turnover
of laboratory technicians in all types of hospitals costs
time and money (SP9). Delays can also happen if pa-
tients cannot find doctors in the afternoon hours or if
they need to get tested across different laboratory facil-
ities on campus. Some patients come to hospitals after
unsuccessfully seeking care elsewhere and may not give
accurate accounts of their history forcing doctors to
repeat tests.
Further delays can happen due to a lack of manpower
to transport samples and reports to and from laborator-
ies, and misplacement of records. To overcome that
challenge, private reference laboratories send ‘collection
boys’ daily to collect samples at private secondary care
hospitals and bring back results after 48 hours (PP5, LT
9, SP 9). In public tertiary care hospitals, samples are re-
ferred to outside reference laboratories only if patients
can afford it and taken there by the patient’s relatives
(SP 1, 2).
Moreover, where some doctors also practice in private
clinics, patients may have to follow doctors to a different
location or end up in the wrong one, another disruption
to the single patient encounter (SP 4,5,7, 11,16, Hospital
Manager 1).
Our finding that the majority of rapid tests are done in
hospital laboratories and thus are not used to their full
potential, highlights that rapid tests are not always com-
pleted rapidly [36–38]. Manpower, workload, equipment,
facilities and cost can cause additional delays further
extending the TATs of (rapid) tests conducted in hos-
pital laboratories and compromising their potential to
ensure the POC continuum. The specific testing infra-
structure of vertical disease programs can further
compound diagnostic delays. Integrating vertical dis-
ease control strategies into the general health systems
[7] would therefore need to involve basic infrastruc-
tural adjustments, such as centralizing laboratories
across hospital campuses.
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Conclusions
In this study, we have for the first time used qualitative
methods to document the use of POC tests across the
spectrum of settings and diseases in the Indian health
care system.
Successful POC testing hardly occurs in any of the five
settings. Our findings suggest that rapid tests are not be-
ing used to their full potential as POC testing programs:
instead, they are used in laboratories of public clinics
and hospitals with too long TATs, leading to patients
having to come back the next day. In the public sector,
lab-based testing in a context of manpower and equip-
ment shortages leads to delays and disruptions in the
POC continuum. In settings where TAT would be shorter
(e.g. in communities, in small peripheral laboratories),
rapid tests are not being used because of non-availability
(public) and too high cost of reagents (small private la-
boratories), or lack of faith in their accuracy (private
clinics). In settings where POC continuums are being en-
sured, the tests used are not always rapid tests. Private la-
boratories and clinics ensure a POC continuum without
specific rapid technologies by relying on older and often
cheaper methods and aligning opening hours and their
localities through established coordination arrangements
to keep TATs at a minimum.
In homes, cost of testing devices and strips restrict
testing to the affluent and educated. While ideally the
use of POC testing at home should ensure that patients
only visit a laboratory or a doctor with positive or abnor-
mal results, we found that patients who use these tests
still visit doctors for confirmation or to read results
correctly. This is compounded by widespread medical
paternalism and lack of counselling in both doctor - patient
and laboratory technician – patient encounters. Thus,
POC tests are not fulfilling their purpose in this setting
and future home-testing will require robust support
and counselling strategies that are sufficiently linked
to patients’ homes [39].
In all settings, the TATs of all tests are potentially
compromised because the onus is on patients to ensure
POC continuums: patients often have to travel to per-
ipheral laboratories (or a different facility in the same
setting) to give samples and bring results back to doc-
tors. POC continuums are further compromised by weak
referral systems between providers, lack of functioning
support for patients (CHWs constrained by workload
and transportation) and patient loss to other providers.
We conclude that the mere availability of rapid so-
called POC tests does not guarantee their scale up or
use in a way that preserves the integrity of the single
patient encounter to facilitate immediate treatment. In
reality, it is compromised by intervening factors such as
costs, availability, arrangements that encourage use of
laboratories, disbelief in accuracy of rapid tests, reliance
on patient initiative to collect results and follow-up with
treatment and patients switching providers. Patients’
self-referrals and time-saving tactics as well as laboratory
technicians’ additional testing or counselling can turn
the diagnostic process on its head with unclear implica-
tions for the POC continuum.
Our study confirms what has been argued elsewhere,
that tests by themselves cannot be called POC or not; it
is how the tests are deployed or implemented that define
POC testing [1]. Integration within the existing health
system is crucial. Our findings show how arrangements
between providers matter for the POC continuum. Simi-
larly, systems for rapid reporting of test results to care
providers, real-world workflow patterns, infrastructural
set-ups linked to disease control strategies and eco-
nomic/incentive structures are as important as the test
itself. Designers of rapid tests, global health experts and
policy-makers need to account for these ground realities
and modify design strategies and policies accordingly.
In this exploratory approach we have identified how
tests are used across the five different settings. Future
studies could examine these different uses on a larger
scale or for specific diseases and tests.
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